US firm Eli Lilly, which is also pushing for end to rebate scheme, optimistic about talks with ministersThe US pharmaceutical group behind the Mounjaro weight-loss drug has said it will unpause its UK investments if ministers agree to regularly increase NHS drug prices and end a rebate scheme.Patrik Jonsson, the president of Eli Lilly’s international business, said the company was…
Source: World news | The Guardian